Thrombocytémie essentielle et grossesse

[1]  C. Bloomfield,et al.  Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. , 2007, Blood.

[2]  M. Cazzola,et al.  Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation. , 2007, Blood.

[3]  P. Campbell,et al.  Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders , 2005, The Lancet.

[4]  M. Cazzola.  Towards a rational treatment of essential thrombocythemia, despite limited evidence and old prejudices. , 2004, Haematologica.

[5]  N. Nathan,et al.  Analgésie péridurale chez une femme enceinte atteinte d’une thrombocytémie essentielle , 2003 .

[6]  T. Lecompte,et al.  Accouchement, analgésie péridurale et thrombocytémie essentielle : évaluation des fonctions plaquettaires et du risque hémorragique , 2003 .

[7]  M. Griesshammer,et al.  Acquired thrombophilia in pregnancy: essential thrombocythemia. , 2003, Seminars in thrombosis and hemostasis.

[8]  D. Vanstraelen,et al.  Management of Essential Thrombocythemia during Pregnancy with Aspirin, Interferon Alpha-2a and No Treatment , 2002, Acta Haematologica.

[9]  R. Fanin,et al.  Pregnancy and abortion in women with essential thrombocythemia , 2002, American journal of hematology.

[10]  N. Nathan,et al.  Platelet function during pregnancy: an evaluation using the PFA-100 analyser. , 2001, British journal of anaesthesia.

[11]  A. Tefferi,et al.  A single institutional experience with 43 pregnancies in essential thrombocythemia , 2001, European journal of haematology.

[12]  M. Bangerter,et al.  Pregnancy in essential thrombocythaemia: treatment and outcome of 17 pregnancies , 2000, European journal of haematology.

[13]  G. Koren,et al.  Hydroxyurea use during pregnancy: A case report in sickle cell disease and review of the literature , 1999, American journal of hematology.

[14]  M. Griesshammer,et al.  Fertility, pregnancy and the management of myeloproliferative disorders. , 1998, Bailliere's clinical haematology.

[15]  Gruppo Italiano Studio Policitemia.  Low‐dose aspirin in polycythaemia vera: a pilot study , 1997 .

[16]  P. Pagliaro,et al.  Primary thrombocythemia and pregnancy: Treatment and outcome in fifteen cases , 1996 .

[17]  V. Krishnamurthy,et al.  Essential Thrombocythemia and Epidural Analgesia in the Parturient: Does Thromboelastography Help? , 1996, Regional Anesthesia & Pain Medicine.

[18]  A. Tefferi,et al.  Outcome analysis of 34 pregnancies in women with essential thrombocythemia. , 1995, Archives of internal medicine.

[19]  N. Jackson,et al.  Hydroxyurea treatment for chronic myeloid leukaemia during pregnancy , 1993, British journal of haematology.

[20]  J. Hull,et al.  Use of h droxyurea in chronic myeloid leukemia during pregnancy: A case report , 1991 .

[21]  Q. S. Ringenberg,et al.  Antineoplastic agents and pregnancy. , 1989, Seminars in oncology.

[22]  G. D'anjou,et al.  Primary thrombocythemia in pregnancy: a report of two cases. , 1988, American journal of obstetrics and gynecology.

[23]  G. Pineo,et al.  Essential thrombocythemia associated with recurrent abortions and fetal growth retardation , 1987, American journal of hematology.

[24]  D. Goldfinger,et al.  Long‐Term Plateletpheresis in the Management of Primary Thrombocytosis , 1979, Transfusion.